57 results on '"ixekizumab"'
Search Results
2. Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight (TOGETHER-PsO)
3. Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight (TOGETHER-PsA)
4. Effects of Interleukin (IL)-17A Inhibition on Idiopathic Subglottic Stenosis
5. Targeting IL-17A for Treatment-Resistant Depression
6. Proactive TDM Versus Standard Use of Biologics in Psoriasis (HELIOS)
7. Korean College of Rheumatology Biologics and Targeted Therapy Registry (KOBIO)
8. Efficacy and Safety of Ixekizumab in Patients With Refractory Guttate Psoriasis
9. Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris
10. A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
11. An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum
12. Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio)
13. Immunoclassification of Psoriasis: a Strategy for Precision Medicine
14. Ixekizumab Diabetes Intervention Trial (I-DIT) (I-DIT)
15. COVID-19 VaccinE Response in Rheumatology Patients (COVER)
16. Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
17. Molecular Signatures in Inflammatory Skin Disease (MSID)
18. A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis
19. Study of Ixekizumab in Healthy Participants
20. Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
21. Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
22. Survival TRial Using CytoKines in COVID-19 (STRUCK Trial) (STRUCK)
23. A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis
24. A Study of Two Formulations of Ixekizumab in Healthy Participants
25. Sequential Treatment of Psoriasis With Traditional Chinese and Western Medicine
26. Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis (Ixora-peds)
27. A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis
28. A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
29. A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis (SPIRIT-H2H)
30. A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) (UNCOVER-3)
31. A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris
32. A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-R)
33. A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis (SPIRIT-P2)
34. Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
35. A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis (COAST-W)
36. A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)
37. A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis (IXORA-P)
38. A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) (UNCOVER-2)
39. A Study of Ixekizumab in Healthy Participants
40. Ixekizumab in the Treatment of Bullous Pemphigoid
41. A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis (COAST-X)
42. A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis (COAST-V)
43. A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis (SPIRIT P3)
44. A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment
45. A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-1)
46. A Study in Participants With Moderate to Severe Psoriasis
47. Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis (UNCOVER-A)
48. A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis
49. A Study in Japanese Participants With Moderate-to-Severe Psoriasis (UNCOVER-J)
50. A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis (IXORA-Q)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.